News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Amgen Net Profit Rises, Key Drug Meets Goal
July 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK/LOS ANGELES, July 26 (Reuters) - Amgen Inc. on Thursday posted quarterly profit that topped Wall Street expectations, even as sales of its biggest drug, Aranesp, fell 19 percent in the United States amid safety concerns.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Amgen
MORE ON THIS TOPIC
Manufacturing
To Compete in Obesity, Late Entrants Invest Early in Manufacturing
September 23, 2025
·
5 min read
·
Nick Paul Taylor
Mergers & acquisitions
Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition
September 22, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Novartis Looking for Constructive Ways To Bring Down Drug Costs in US
September 22, 2025
·
2 min read
·
Tristan Manalac
IPOs
MapLight Keeps Biopharma’s IPO Flame Alight To Advance Alzheimer’s, Schizophrenia Drugs
September 22, 2025
·
2 min read
·
Tristan Manalac
